AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Eagle Pharmaceuticals, Inc.

$0.16 -$0.18 (-52.56%)
OTC · 11 Sep 2026 19:55 UTC
Previous Close
$0.76
Day Range
$0.16$0.74
Year Range
$0.05$3.87
Market Cap
2.12M
AVG Volume
4.75K
Trailing/Forward PE
0.06/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-09
Primary Exchange
Other OTCUS
Revenue (USD)
0100M200M300M400M2013201420152016201720182019202020212022
EGRX Revenue (USD) by year
PeriodRevenue (USD)
2022316.61M
2021171.55M
2020187.8M
2019195.89M
2018213.31M
2017236.71M
2016189.48M
201566.23M
201419.21M
201317.69M
Net Income (USD)
-50M050M100M2013201420152016201720182019202020212022
EGRX Net Income (USD) by year
PeriodNet Income (USD)
202239.26M
2021-8.63M
202011.99M
201914.31M
201831.91M
201751.94M
201681.46M
20152.57M
2014-20.23M
2013-6.82M
Operating Income (USD)
-25M025M50M75M2013201420152016201720182019202020212022
EGRX Operating Income (USD) by year
PeriodOperating Income (USD)
202269.19M
20212.77M
202032.95M
201921.82M
201836.62M
201773.99M
201653.35M
20152.56M
2014-22.26M
2013-8.64M
EBITDA (USD)
-50M050M100M2013201420152016201720182019202020212022
EGRX EBITDA (USD) by year
PeriodEBITDA (USD)
202284.48M
20212.03M
202029.04M
201929.34M
201840.45M
201777.83M
201655.03M
20152.69M
2014-22.24M
2013-8.61M
Cash Flows (USD)
-40M-20M020M40M60M2013201420152016201720182019202020212022
EGRX Cash Flows (USD) by year
PeriodCash Flows (USD)
202250.52M
202127.9M
202048.75M
201955.21M
201852.25M
201753.73M
201632.52M
2015-11.6M
2014-21.79M
2013-4.1M
EPS (USD)
-202462013201420152016201720182019202020212022
EGRX EPS (USD) by year
PeriodEPS (USD)
20223.02
2021-0.67
20200.87
20191
20182.11
20173.26
20164.99
20150.2
2014-1.55
2013-0.56
Expenses (USD)
050M100M150MR&DSG&ACapex2013201420152016201720182019202020212022
EGRX Expenses (USD) by year
PeriodExpenses (USD)
2022140.89M
2021126.92M
2020110.13M
2019113.96M
2018105.09M
2017110.06M
2016103.26M
201549.9M
201429.94M
201314.58M
Cash & Debt (USD)
050M100M150MCashLong Term DebtShort Term Debt2013201420152016201720182019202020212022
EGRX Cash & Debt (USD) by year
PeriodCash & Debt (USD)
202255.32M
202197.66M
2020103.16M
2019109.78M
201878.79M
2017114.66M
201652.82M
201579.08M
201434.87M
20139.97M
Debt ratios
-2-1012016201720182019202020212022
EGRX Debt ratios by year
PeriodDebt ratios
20220.05
2021-0.71
2020-0.37
2019-0.35
2018-0.2
2017-0.59
2016-1.97
Margins
0%20%40%60%80%2013201420152016201720182019202020212022
EGRX Margins by year
PeriodMargins
202270.01%
202175.41%
202075.79%
201968.91%
201870.97%
201775.84%
201670.81%
201576.37%
201439.72%
201333.32%
Return on Capital
-1000%-750%-500%-250%0%250%2013201420152016201720182019202020212022
EGRX Return on Capital by year
PeriodReturn on Capital
202216.81%
2021-4.89%
20206.45%
20197.99%
201819.85%
201729%
201653.86%
20152.85%
2014-72.48%
2013-880.45%
Shares Outstanding
05M10M15M20M2013201420152016201720182019202020212022
EGRX Shares Outstanding by year
PeriodShares Outstanding
202213.02M
202112.9M
202013.48M
201913.65M
201814.37M
201714.89M
201615.29M
201515.6M
201414.03M
201313.92M
Book Value Per Share (USD)
051015202013201420152016201720182019202020212022
EGRX Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
202217.94
202113.68
202013.8
201913.13
201811.19
201712.03
20169.89
20155.79
20141.99
20130.06
Total Assets (USD)
0200M400M600M2013201420152016201720182019202020212022
EGRX Total Assets (USD) by year
PeriodTotal Assets (USD)
2022406.16M
2021253.73M
2020253.19M
2019254.55M
2018238.6M
2017270.06M
2016213.57M
2015124.61M
201450.09M
201318.01M
Employee Count
050100150201420152016201720182019202020212022
EGRX Employee Count by year
PeriodEmployee Count
2022134
2021102
2020106
2019108
201896
2017108
201677
201541
201428
PE Ratio
01234med 0.61Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EGRX PE Ratio by year
PeriodPE Ratio
Sep 260.14
Sep 260.63
Aug 260.78
Aug 260.45
Aug 260.5
Aug 260.04
Jul 260.31
Jul 260.31
Jul 260.5
Jul 260.56
Jul 260.56
Jun 260.56
Jun 260.52
Jun 260.5
Jun 260.5
May 260.48
May 260.32
May 260.32
May 260.32
May 260.4
Apr 260.32
Apr 260.29
Apr 260.29
Apr 260.21
Mar 260.29
Mar 260.07
Mar 260.29
Mar 260.13
Feb 260.13
Feb 260.17
Feb 260.21
Feb 260.21
Jan 260.21
Jan 260.59
Jan 260.42
Jan 260.32
Jan 260.29
Dec 250.28
Dec 250.25
Dec 250.46
Dec 250.59
Nov 250.42
Nov 250.66
Nov 251.09
Nov 251.26
Oct 250.59
Oct 250.84
Oct 251.26
Oct 251.35
Oct 252.52
Sep 252.27
Sep 252.83
Sep 252.7
Sep 252.55
Aug 252.6
Aug 252.68
Aug 252.69
Aug 252.68
Aug 252.68
Jul 253.1
Jul 253.11
Jul 252.99
Jul 252.52
Jun 252.44
Jun 252.42
Jun 252.02
Jun 251.89
May 251.6
May 251.68
May 251.63
May 251.67
May 251.66
Apr 251.43
Apr 251.51
Apr 251.01
Apr 251.58
Mar 250.74
Mar 251.25
Mar 251.09
Mar 250.71
Feb 251.01
Feb 251.25
Feb 250.98
Feb 250.76
Jan 250.67
Jan 250.82
Jan 250.55
Jan 250.55
Jan 250.34
Dec 240.42
Dec 240.46
Dec 240.63
Dec 240.71
Nov 240.6
Nov 240.8
Nov 240.55
Nov 240.72
Nov 240.46
Oct 240.5
Oct 240.76
Free Cash Flow Yield
-1500%-1000%-500%0%med -98.35%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EGRX Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-444.79%
Sep 26-95.66%
Aug 26-77.56%
Aug 26-135.37%
Aug 26-120.58%
Aug 26-1409.52%
Jul 26-193.9%
Jul 26-193.9%
Jul 26-120.58%
Jul 26-107.08%
Jul 26-107.08%
Jun 26-107.08%
Jun 26-116.66%
Jun 26-119.57%
Jun 26-119.57%
May 26-124.77%
May 26-186.35%
May 26-191.32%
May 26-188.8%
May 26-151.04%
Apr 26-188.8%
Apr 26-204.99%
Apr 26-210.4%
Apr 26-286.92%
Mar 26-210.4%
Mar 26-844.06%
Mar 26-210.4%
Mar 26-478.3%
Feb 26-478.3%
Feb 26-358.72%
Feb 26-286.98%
Feb 26-286.98%
Jan 26-286.98%
Jan 26-102.49%
Jan 26-143.49%
Jan 26-188.8%
Jan 26-211.01%
Dec 25-217.41%
Dec 25-239.15%
Dec 25-130.45%
Dec 25-102.49%
Nov 25-143.49%
Nov 25-91.98%
Nov 25-55.19%
Nov 25-47.83%
Oct 25-102.49%
Oct 25-71.74%
Oct 25-47.83%
Oct 25-44.84%
Oct 25-23.91%
Sep 25-26.57%
Sep 25-21.29%
Sep 25-22.35%
Sep 25-23.68%
Aug 25-23.22%
Aug 25-22.49%
Aug 25-22.42%
Aug 25-22.49%
Aug 25-22.49%
Jul 25-19.44%
Jul 25-19.39%
Jul 25-20.21%
Jul 25-23.91%
Jun 25-24.74%
Jun 25-24.91%
Jun 25-29.89%
Jun 25-31.89%
May 25-37.76%
May 25-35.87%
May 25-36.98%
May 25-36.05%
May 25-36.42%
Apr 25-42.2%
Apr 25-39.86%
Apr 25-59.79%
Apr 25-38.16%
Mar 25-81.53%
Mar 25-48.15%
Mar 25-55.19%
Mar 25-84.41%
Feb 25-59.79%
Feb 25-48.15%
Feb 25-61.32%
Feb 25-79.72%
Jan 25-89.68%
Jan 25-73.21%
Jan 25-110.38%
Jan 25-110.38%
Jan 25-174.99%
Dec 24-143.49%
Dec 24-130.45%
Dec 24-95.66%
Dec 24-84.41%
Nov 24-101.05%
Nov 24-75.52%
Nov 24-110.33%
Nov 24-84.31%
Nov 24-130.45%
Oct 24-119.57%
Oct 24-79.72%
Price to Sales
00.050.10.150.2med 0.04Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EGRX Price to Sales by year
PeriodPrice to Sales
Sep 260.01
Sep 260.04
Aug 260.05
Aug 260.03
Aug 260.03
Aug 260
Jul 260.02
Jul 260.02
Jul 260.03
Jul 260.03
Jul 260.03
Jun 260.03
Jun 260.03
Jun 260.03
Jun 260.03
May 260.03
May 260.02
May 260.02
May 260.02
May 260.02
Apr 260.02
Apr 260.02
Apr 260.02
Apr 260.01
Mar 260.02
Mar 260
Mar 260.02
Mar 260.01
Feb 260.01
Feb 260.01
Feb 260.01
Feb 260.01
Jan 260.01
Jan 260.04
Jan 260.03
Jan 260.02
Jan 260.02
Dec 250.02
Dec 250.02
Dec 250.03
Dec 250.04
Nov 250.03
Nov 250.04
Nov 250.07
Nov 250.08
Oct 250.04
Oct 250.05
Oct 250.08
Oct 250.08
Oct 250.15
Sep 250.14
Sep 250.17
Sep 250.16
Sep 250.15
Aug 250.16
Aug 250.16
Aug 250.16
Aug 250.16
Aug 250.16
Jul 250.19
Jul 250.19
Jul 250.18
Jul 250.15
Jun 250.15
Jun 250.15
Jun 250.12
Jun 250.11
May 250.1
May 250.1
May 250.1
May 250.1
May 250.1
Apr 250.09
Apr 250.09
Apr 250.06
Apr 250.1
Mar 250.04
Mar 250.08
Mar 250.07
Mar 250.04
Feb 250.06
Feb 250.08
Feb 250.06
Feb 250.05
Jan 250.04
Jan 250.05
Jan 250.03
Jan 250.03
Jan 250.02
Dec 240.03
Dec 240.03
Dec 240.04
Dec 240.04
Nov 240.04
Nov 240.05
Nov 240.03
Nov 240.04
Nov 240.03
Oct 240.03
Oct 240.05
EV/EBITDA
0.7511.251.51.752med 1.16Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EGRX EV/EBITDA by year
PeriodEV/EBITDA
Sep 261.02
Sep 261.16
Aug 261.2
Aug 261.11
Aug 261.12
Aug 261
Jul 261.07
Jul 261.07
Jul 261.12
Jul 261.14
Jul 261.14
Jun 261.14
Jun 261.13
Jun 261.13
Jun 261.13
May 261.12
May 261.08
May 261.07
May 261.07
May 261.1
Apr 261.07
Apr 261.07
Apr 261.07
Apr 261.04
Mar 261.07
Mar 261.01
Mar 261.07
Mar 261.02
Feb 261.02
Feb 261.03
Feb 261.04
Feb 261.04
Jan 261.04
Jan 261.15
Jan 261.1
Jan 261.07
Jan 261.07
Dec 251.06
Dec 251.06
Dec 251.11
Dec 251.15
Nov 251.1
Nov 251.17
Nov 251.29
Nov 251.33
Oct 251.15
Oct 251.22
Oct 251.33
Oct 251.35
Oct 251.68
Sep 251.61
Sep 251.76
Sep 251.72
Sep 251.68
Aug 251.7
Aug 251.72
Aug 251.72
Aug 251.72
Aug 251.72
Jul 251.84
Jul 251.84
Jul 251.8
Jul 251.68
Jun 251.65
Jun 251.65
Jun 251.54
Jun 251.5
May 251.42
May 251.45
May 251.43
May 251.44
May 251.44
Apr 251.38
Apr 251.4
Apr 251.26
Apr 251.42
Mar 251.19
Mar 251.33
Mar 251.29
Mar 251.18
Feb 251.26
Feb 251.33
Feb 251.26
Feb 251.19
Jan 251.17
Jan 251.21
Jan 251.14
Jan 251.14
Jan 251.08
Dec 241.1
Dec 241.11
Dec 241.16
Dec 241.18
Nov 241.15
Nov 241.21
Nov 241.14
Nov 241.18
Nov 241.11
Oct 241.13
Oct 241.19
Price/Operating Cashflow
0200400600med 15.92Nov 21Feb 22Jun 22Sep 22Jan 23Apr 23Aug 23
EGRX Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Aug 238.32
Jul 237.19
Jul 237.58
Jul 237.1
Jul 237.46
Jun 237.51
Jun 237.95
Jun 237.29
Jun 237.29
Jun 238.32
May 237.9
May 238.2
May 237.96
May 237.36
Apr 237.21
Apr 237.09
Apr 237.63
Apr 238.18
Mar 237.28
Mar 236.82
Mar 2315.94
Mar 2315.55
Mar 2316.77
Feb 2317.88
Feb 2319.11
Feb 2319.23
Feb 2320.79
Jan 2320.94
Jan 2321.04
Jan 2320.13
Jan 2318.9
Dec 2218.13
Dec 2218.06
Dec 2218.19
Dec 2219.26
Dec 2222.28
Nov 2222.26
Nov 2223.3
Nov 2223.33
Nov 2211.4
Oct 2211.9
Oct 2211.05
Oct 229.97
Oct 229.41
Sep 229.55
Sep 229.75
Sep 2210.45
Sep 2211.31
Sep 2211.65
Aug 2212.98
Aug 2213.66
Aug 2212.93
Aug 22484.24
Jul 22446.56
Jul 22452.63
Jul 22504.26
Jul 22516.86
Jul 22525.19
Jun 22476.71
Jun 22474.34
Jun 22496.73
Jun 22532.05
May 22546.11
May 22525.41
May 22494.93
May 2219.77
Apr 2220.17
Apr 2222.12
Apr 2223.05
Apr 2223.47
Apr 2223.44
Mar 2221.47
Mar 2222.5
Mar 2223.19
Mar 2214.78
Feb 2215.35
Feb 2215.13
Feb 2215.91
Feb 2214.61
Jan 2214.87
Jan 2215.32
Jan 2215.47
Jan 2216.59
Dec 2116.69
Dec 2117.93
Dec 2117.81
Dec 2115.02
Dec 2115.54
Nov 2115.76
Nov 2116.21
Nov 2116.88
Nov 2115.28
Oct 2115.44
Oct 2115.42
Oct 2116.03
Oct 2116.46
Oct 2116.78
Sep 2115.96
Sep 2114.53
Sep 2115.24
Price to Book
00.050.10.150.2med 0.04Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EGRX Price to Book by year
PeriodPrice to Book
Sep 260.01
Sep 260.04
Aug 260.05
Aug 260.03
Aug 260.03
Aug 260
Jul 260.02
Jul 260.02
Jul 260.03
Jul 260.03
Jul 260.03
Jun 260.03
Jun 260.03
Jun 260.03
Jun 260.03
May 260.03
May 260.02
May 260.02
May 260.02
May 260.02
Apr 260.02
Apr 260.02
Apr 260.02
Apr 260.01
Mar 260.02
Mar 260
Mar 260.02
Mar 260.01
Feb 260.01
Feb 260.01
Feb 260.01
Feb 260.01
Jan 260.01
Jan 260.04
Jan 260.03
Jan 260.02
Jan 260.02
Dec 250.02
Dec 250.02
Dec 250.03
Dec 250.04
Nov 250.03
Nov 250.04
Nov 250.07
Nov 250.08
Oct 250.04
Oct 250.05
Oct 250.08
Oct 250.08
Oct 250.16
Sep 250.14
Sep 250.18
Sep 250.17
Sep 250.16
Aug 250.16
Aug 250.17
Aug 250.17
Aug 250.17
Aug 250.17
Jul 250.19
Jul 250.19
Jul 250.18
Jul 250.16
Jun 250.15
Jun 250.15
Jun 250.12
Jun 250.12
May 250.1
May 250.1
May 250.1
May 250.1
May 250.1
Apr 250.09
Apr 250.09
Apr 250.06
Apr 250.1
Mar 250.05
Mar 250.08
Mar 250.07
Mar 250.04
Feb 250.06
Feb 250.08
Feb 250.06
Feb 250.05
Jan 250.04
Jan 250.05
Jan 250.03
Jan 250.03
Jan 250.02
Dec 240.03
Dec 240.03
Dec 240.04
Dec 240.04
Nov 240.04
Nov 240.05
Nov 240.03
Nov 240.04
Nov 240.03
Oct 240.03
Oct 240.05
Eagle Pharmaceuticals, Inc.
EGRX
Stockpicker

Video analysis: EGRX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: EGRX

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.